Advertisement
Trial may lead to first FDA approval in this realm
Fat necrosis is a benign but real concern
Phase 1b trial shows good response rate
Cardiac dosing 50 percent below national average
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Full treatment in five fractions
Investigating cell-free nucleic acids for cancer detection
Microsurgery technique may provide relief to patients
Researchers testing innovative design
Multimodal analgesia under study
Discovery of mechanistic links may lead to new therapies
Advertisement
Advertisement